Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression

Mark A Frye, June Watzl, Shida Banakar, Joseph O'Neill, Jim Mintz, Pablo Davanzo, Jeffrey Fischer, Jason W. Chirichigno, Joseph Ventura, Shana Elman, John Tsuang, Irwin Walot, M. Albert Thomas

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

Proton magnetic resonance spectroscopy (1HMRS) is an in vivo brain imaging method that can be used to investigate psychotropic drug mechanism of action. This study evaluated baseline 1HMRS spectra of bipolar depressed patients and whether the level of cerebral metabolites changed after an open trial of lamotrigine, an anti-glutamatergic mood stabilizer. Twenty-three bipolar depressed and 12 control subjects underwent a MRS scan of the anterior cingulate/medial prefrontal cortex. The scan was performed on a GE whole-body 1.5 T MRI scanner using single-voxel PRESS (TE/TR=30/3000 ms, 3 × 3 × 3 cm3 and post-processed offline with LCModel. Baseline CSF-corrected absolute concentrations of glutamate+glutamine ([Glx]), glutamate ([Glu]), and creatine+phosphocreatine ([Cr]) were significantly higher in bipolar depressed subjects vs healthy controls. The non-melancholic subtype had significantly higher baseline [Glx] and [Glu] levels than the melancholic subtype. Remission with lamotrigine was associated with significantly lower post-treatment glutamine ([Gln]) in comparison to non-remission. These data suggest that non-melancholic bipolar depression is characterized by increased glutamate coupled with increased energy expenditure. Lamotrigine appears to reduce glutamine levels associated with treatment remission. Further study is encouraged to determine if these MR spectroscopic markers can delineate drug mechanism of action and subsequent treatment response.

Original languageEnglish (US)
Pages (from-to)2490-2499
Number of pages10
JournalNeuropsychopharmacology
Volume32
Issue number12
DOIs
StatePublished - Dec 2007

Fingerprint

Creatine
Gyrus Cinguli
Bipolar Disorder
Glutamic Acid
Glutamine
Phosphocreatine
Psychotropic Drugs
Prefrontal Cortex
Neuroimaging
Energy Metabolism
Healthy Volunteers
Therapeutics
Pharmaceutical Preparations
lamotrigine

Keywords

  • Bipolar
  • Depression
  • Glutamate
  • Lamotrigine
  • MR spectroscopy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. / Frye, Mark A; Watzl, June; Banakar, Shida; O'Neill, Joseph; Mintz, Jim; Davanzo, Pablo; Fischer, Jeffrey; Chirichigno, Jason W.; Ventura, Joseph; Elman, Shana; Tsuang, John; Walot, Irwin; Thomas, M. Albert.

In: Neuropsychopharmacology, Vol. 32, No. 12, 12.2007, p. 2490-2499.

Research output: Contribution to journalArticle

Frye, MA, Watzl, J, Banakar, S, O'Neill, J, Mintz, J, Davanzo, P, Fischer, J, Chirichigno, JW, Ventura, J, Elman, S, Tsuang, J, Walot, I & Thomas, MA 2007, 'Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression', Neuropsychopharmacology, vol. 32, no. 12, pp. 2490-2499. https://doi.org/10.1038/sj.npp.1301387
Frye, Mark A ; Watzl, June ; Banakar, Shida ; O'Neill, Joseph ; Mintz, Jim ; Davanzo, Pablo ; Fischer, Jeffrey ; Chirichigno, Jason W. ; Ventura, Joseph ; Elman, Shana ; Tsuang, John ; Walot, Irwin ; Thomas, M. Albert. / Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. In: Neuropsychopharmacology. 2007 ; Vol. 32, No. 12. pp. 2490-2499.
@article{365301bf0a2246fb853c05af404afcf2,
title = "Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression",
abstract = "Proton magnetic resonance spectroscopy (1HMRS) is an in vivo brain imaging method that can be used to investigate psychotropic drug mechanism of action. This study evaluated baseline 1HMRS spectra of bipolar depressed patients and whether the level of cerebral metabolites changed after an open trial of lamotrigine, an anti-glutamatergic mood stabilizer. Twenty-three bipolar depressed and 12 control subjects underwent a MRS scan of the anterior cingulate/medial prefrontal cortex. The scan was performed on a GE whole-body 1.5 T MRI scanner using single-voxel PRESS (TE/TR=30/3000 ms, 3 × 3 × 3 cm3 and post-processed offline with LCModel. Baseline CSF-corrected absolute concentrations of glutamate+glutamine ([Glx]), glutamate ([Glu]), and creatine+phosphocreatine ([Cr]) were significantly higher in bipolar depressed subjects vs healthy controls. The non-melancholic subtype had significantly higher baseline [Glx] and [Glu] levels than the melancholic subtype. Remission with lamotrigine was associated with significantly lower post-treatment glutamine ([Gln]) in comparison to non-remission. These data suggest that non-melancholic bipolar depression is characterized by increased glutamate coupled with increased energy expenditure. Lamotrigine appears to reduce glutamine levels associated with treatment remission. Further study is encouraged to determine if these MR spectroscopic markers can delineate drug mechanism of action and subsequent treatment response.",
keywords = "Bipolar, Depression, Glutamate, Lamotrigine, MR spectroscopy",
author = "Frye, {Mark A} and June Watzl and Shida Banakar and Joseph O'Neill and Jim Mintz and Pablo Davanzo and Jeffrey Fischer and Chirichigno, {Jason W.} and Joseph Ventura and Shana Elman and John Tsuang and Irwin Walot and Thomas, {M. Albert}",
year = "2007",
month = "12",
doi = "10.1038/sj.npp.1301387",
language = "English (US)",
volume = "32",
pages = "2490--2499",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression

AU - Frye, Mark A

AU - Watzl, June

AU - Banakar, Shida

AU - O'Neill, Joseph

AU - Mintz, Jim

AU - Davanzo, Pablo

AU - Fischer, Jeffrey

AU - Chirichigno, Jason W.

AU - Ventura, Joseph

AU - Elman, Shana

AU - Tsuang, John

AU - Walot, Irwin

AU - Thomas, M. Albert

PY - 2007/12

Y1 - 2007/12

N2 - Proton magnetic resonance spectroscopy (1HMRS) is an in vivo brain imaging method that can be used to investigate psychotropic drug mechanism of action. This study evaluated baseline 1HMRS spectra of bipolar depressed patients and whether the level of cerebral metabolites changed after an open trial of lamotrigine, an anti-glutamatergic mood stabilizer. Twenty-three bipolar depressed and 12 control subjects underwent a MRS scan of the anterior cingulate/medial prefrontal cortex. The scan was performed on a GE whole-body 1.5 T MRI scanner using single-voxel PRESS (TE/TR=30/3000 ms, 3 × 3 × 3 cm3 and post-processed offline with LCModel. Baseline CSF-corrected absolute concentrations of glutamate+glutamine ([Glx]), glutamate ([Glu]), and creatine+phosphocreatine ([Cr]) were significantly higher in bipolar depressed subjects vs healthy controls. The non-melancholic subtype had significantly higher baseline [Glx] and [Glu] levels than the melancholic subtype. Remission with lamotrigine was associated with significantly lower post-treatment glutamine ([Gln]) in comparison to non-remission. These data suggest that non-melancholic bipolar depression is characterized by increased glutamate coupled with increased energy expenditure. Lamotrigine appears to reduce glutamine levels associated with treatment remission. Further study is encouraged to determine if these MR spectroscopic markers can delineate drug mechanism of action and subsequent treatment response.

AB - Proton magnetic resonance spectroscopy (1HMRS) is an in vivo brain imaging method that can be used to investigate psychotropic drug mechanism of action. This study evaluated baseline 1HMRS spectra of bipolar depressed patients and whether the level of cerebral metabolites changed after an open trial of lamotrigine, an anti-glutamatergic mood stabilizer. Twenty-three bipolar depressed and 12 control subjects underwent a MRS scan of the anterior cingulate/medial prefrontal cortex. The scan was performed on a GE whole-body 1.5 T MRI scanner using single-voxel PRESS (TE/TR=30/3000 ms, 3 × 3 × 3 cm3 and post-processed offline with LCModel. Baseline CSF-corrected absolute concentrations of glutamate+glutamine ([Glx]), glutamate ([Glu]), and creatine+phosphocreatine ([Cr]) were significantly higher in bipolar depressed subjects vs healthy controls. The non-melancholic subtype had significantly higher baseline [Glx] and [Glu] levels than the melancholic subtype. Remission with lamotrigine was associated with significantly lower post-treatment glutamine ([Gln]) in comparison to non-remission. These data suggest that non-melancholic bipolar depression is characterized by increased glutamate coupled with increased energy expenditure. Lamotrigine appears to reduce glutamine levels associated with treatment remission. Further study is encouraged to determine if these MR spectroscopic markers can delineate drug mechanism of action and subsequent treatment response.

KW - Bipolar

KW - Depression

KW - Glutamate

KW - Lamotrigine

KW - MR spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=36248931550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36248931550&partnerID=8YFLogxK

U2 - 10.1038/sj.npp.1301387

DO - 10.1038/sj.npp.1301387

M3 - Article

C2 - 17429412

AN - SCOPUS:36248931550

VL - 32

SP - 2490

EP - 2499

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 12

ER -